Latest Trace Neuroscience News & Updates

See the latest news and media coverage for Trace Neuroscience. We track all announcements, press releases, and industry mentions in real time, all in one place.

Trace Neuroscience

Biotechnology company developing genetic medicines for ALS

traceneuro.com

Headquarters: South San Francisco, United States
Founded year: 2024
Company type: Private company
Number of employees: 20–50
Industry: Pharmaceuticals

Last updated October 19

Latest news about Trace Neuroscience

In short: Trace Neuroscience launched with $101M and advanced its UNC13A-targeting ALS therapy TRCN-1023 into trials and partnerships.

Company announcements

October 19 Trace Neuroscience

Trace Neuroscience secures Target ALS funding

Collaborating with UCL, UC Berkeley, and Harvard, Trace investigates circular RNAs to develop biomarkers for tracking TDP-43 loss in ALS patients.

October 17 Trace Neuroscience

Trace Neuroscience is hiring a Director Clinical Scientist in Boston

The organization seeks to fill this leadership role with immediate applications or network shares encouraged.

October 16 Trace Neuroscience

Trace Neuroscience celebrates CEO Eric Green recognition as a top entrepreneur

Eric Green received the Goldman Sachs Builders and Innovators Summit award for exceptional entrepreneurship in 2026.

June 22 Trace Neuroscience

Trace Neuroscience initiates global clinical development for TRCN-1023

The antisense oligonucleotide targets UNC13A protein function to treat ALS across European sites and a Chinese partnership.

Media coverage

August 10 BioPharma Dive

How a Biogen drug set the stage for a new biotech targeting ALS | BioPharma Dive

Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke with BioPharma Dive about how the...

June 22 Nature

Trace Neuroscience

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group...

March 25 BioSpace

Trace Unites ALS Teams Behind a Target That Could Broaden Treatment Access - BioSpace

Trace Neuroscience, a member of BioSpace’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims to bring more treatment options...

April 1, 2025 Yahoo Finance

Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial

Collaboration will support trial planning for Trace Neuroscience’s upcoming Phase 1/2 clinical trial in ALS SAN FRANCISCO & SOUTH SAN FRANCISCO, Calif., April 01, 2025--(BUSINESS...

Never miss news about Trace Neuroscience

Track Trace Neuroscience and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trace Neuroscience competitors & trending companies

Browse news for competitors to Trace Neuroscience and other trending companies.